2Burris HA 3rd, Moore MJ,Andersen J,et al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial [ J ]. J Clin Oncol, 1997, 15(6) :2403-2413.
3Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes[J]. Science, 2002,298(5594) :850-854.
1[1]Rosenberg SA. Adoptive immunotherapy for cancer. Scientific American, 1990, (5): 62.
2[2]Inoue Y. Induction of killer cells from lymphcytes in pleural effusion of advanced lung cancer patients. Jpn J Cancer Res,1990, 81: 1012.
3[3]Brouwenstijn N. Renal -cell carcinoma- specific lysis by cytotoxic T lymphocyte clones isolated from peripheral blood lymphocytes and tumor infiltrating lymphocytes. Int J Cancer,1996, 68: 2177.
4[4]Van den Hove LE. Identification of an enriched CD4+ CD8 alpha+ + CD8 beta+ T - cell subset among tumor - infiltrating lymphocytes in human renal cell carcinoma. Int J Cancer, 1997,71: 2, 178.
5Dudley M E, Wunderlich J R, Robbins P F, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes[J]. Science, 2002,298 (5594): 850-854.
6Kan N. Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes[J]. Gan To Kagaku Ryoho, 2003,30(11): 1559-1561.
7Ridolfi L, Ridolfi R, Riccobon A, et al. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma[J]. J Immunother, 2003,26(2):156-162.
8Lau R, Wang F, Jeffery G, et al. PhaseⅠtrial of intravenous peptide-pulsed dendritic cell in patients with metastatic melanoma[J]. J Immunother, 2001,24(1): 66-78.
9Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell- dendritic cell hybrids[J]. Nat Med,2000,6(3): 332-336.
10Timmerman JM, Czerwinski DK, Davis TA, et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune response in 35 patients[J]. Blood, 2002,99(5):1517-1526.
